Endovascular Therapy for Renal Artery Stenosis in China
A Multicenter Registry of Endovascular Therapy for Renal Artery Stenosis in China
Sponsor: Chinese Academy of Medical Sciences, Fuwai Hospital
Listed as NCT03080519, this NA trial focuses on Hypertension, Renovascular and Renal Artery Obstruction and remains ongoing. Sponsored by Chinese Academy of Medical Sciences, Fuwai Hospital, it has been updated 7 times since 2017, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.
Change History
7 versions recorded-
Sep 2025 — Present [monthly]
Unknown NA
-
Sep 2024 — Sep 2025 [monthly]
Unknown NA
-
Jul 2024 — Sep 2024 [monthly]
Unknown NA
Status: Unknown Status → Unknown
-
May 2024 — Jul 2024 [monthly]
Unknown Status NA
Status: Not Yet Recruiting → Unknown Status
-
Jan 2021 — May 2024 [monthly]
Not Yet Recruiting NA
▶ Show 2 earlier versions
-
Jun 2018 — Jan 2021 [monthly]
Not Yet Recruiting NA
-
Apr 2017 — Jun 2018 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Chinese Academy of Medical Sciences, Fuwai Hospital
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Beijing, China, Chengdu, China, Chongqing, China, Guangzhou, China, Hangzhou, China, Lanzhou, China, Mudanjiang, China, Nanchang, China, Shanghai, China, Shenyang, China and 3 more location s